|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 75, 219-223, Copyright © 1978 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
AI Hartstein, J Jackson and DN Gilbert
Prophylactic antibiotics are prescribed frequently for patients requiring
permanent transvenous cardiac pacemakers, despite a paucity of data
indicating effectiveness. A 10 year retrospective analysis was performed of
298 pacemaker insertion procedures involving 204 patients. On the basis of
prestudy criteria relating to timing and dosage of antibiotics, the use of
prophylactic antibiotics was judged as adequate or inadequate. There were
no postoperative infections in the 108 battery pack replacement procedures
despite no or inadequate use of antibiotics in 49 procedures. There were
nine infections in the 190 battery pack plus pacing wire procedures for an
infection rate of 5 percent. There was no significant difference in
infection rate between the group given prophylactic antibiotics and the
group given no or inadequate prophylactic antibiotics. Of the 190 battery
pack plus pacing wire procedures, no infections occurred in the 50
procedures in which surgical drains were not used (p less than 0.003). In
the 140 procedures in which drains were used, there was no correlation
between wound infection and absent or inadequate coverage with prophylactic
antibiotics. Two severe bacteremic Staphylococcus aureus infections
occurred in two patients not given prophylactic antibiotics. The other
seven infections were clinically indolent. These results suggest the
following: (1) There is no need for prophylactic antibiotics in battery
pack replacement procedures; (2) prophylactic antibiotics may decrease the
severity of infection in battery pack plus pacing wire procedures; (3)
surgical drains should be avoided in battery pack plus pacing wire
procedures. A prospective controlled study is necessary to confirm these
results.
ARTICLES
Prophylactic antibiotics and the insertion of permanent transvenous cardiac pacemakers
This article has been cited by other articles:
![]() |
M.-R. Movahed, B. Kasravi, and C. S. Bryan Prophylactic Use of Vancomycin in Adult Cardiology and Cardiac Surgery Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1): 13 - 20. [Abstract] [PDF] |
||||
![]() |
A. Da Costa, G. Kirkorian, M. Cucherat, F. Delahaye, P. Chevalier, A. Cerisier, K. Isaaz, and P. Touboul Antibiotic Prophylaxis for Permanent Pacemaker Implantation : A Meta-Analysis Circulation, May 19, 1998; 97(18): 1796 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rao and C. A.B. Lima Infection in Cardiac Pacemaker Implantation is Avoidable Vascular and Endovascular Surgery, March 1, 1986; 20(2): 94 - 98. [Abstract] [PDF] |
||||
![]() |
B. A. Chase and S. G. Pauker Recurrent Endocarditis in a Patient with a Permanent Transvenous Pacemaker Med Decis Making, January 1, 1982; 2(2): 225 - 244. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |